Ultra Clean
UCTT
71.42
-1.82
-2.49%
Ultra Clean
US · UCTT
#2399 by market cap
Listed 1970
71.42
-1.82
-2.49%
Live - 5344 symbols - heartbeat 365s ago
· 2026-10-08 07:00
Pre-market
70.00
-1.99%
After-hours
70.45
-1.36%
Overnight
70.10
-1.85%
- Market cap
- 3.23B
- P/E (TTM)i
- -142.84
- P/Bi
- 5.05
- EPSi
- -4.00
- Div yieldi
- 0.00%
- 52W posi
- 41%
Reader sentiment
Are you bullish or bearish on UCTT?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 3.94, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -2.08% YoY
Margins
- Gross margin
- 15.72%
- Operating margin
- 2.13%
- Net margin
- -8.82%
Key ratios & quality
- Enterprise valuei
- 3.42B
- Altman Z-Scorei
- 3.94
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.10B | 1.07B | 1.40B | 2.10B | 2.37B | 1.73B | 2.10B | 2.05B |
| Gross profit | 175.80M | 196.80M | 291.80M | 430.00M | 465.00M | 277.30M | 356.30M | 322.90M |
| Selling & admin expenses | 101.80M | 152.30M | 155.60M | 219.80M | 238.70M | 213.80M | 236.80M | 247.20M |
| Research & development | 13.30M | 14.60M | 14.80M | 24.50M | 28.50M | 28.30M | 28.30M | 32.00M |
| Operating profit | 60.70M | 29.90M | 121.40M | 185.70M | 197.80M | 35.20M | 91.20M | 43.70M |
| Pretax profit | 52.30M | 2.30M | 99.70M | 154.30M | 88.30M | -11.30M | 67.20M | -145.70M |
| Tax | 15.30M | 10.00M | 19.30M | 27.90M | 37.90M | 10.90M | 32.70M | 25.90M |
| Net profit | 37.00M | -7.70M | 80.40M | 126.40M | 50.40M | -22.20M | 34.50M | -171.60M |
| Basic EPS | 1 | 0 | 2 | 3 | 1 | -1 | 1 | -4 |
| Diluted EPS | 0.94 | -0.24 | 1.89 | 2.69 | 0.88 | -0.70 | 0.52 | -4.00 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 518.60M | 518.80M | 510.00M | 506.70M | 533.70M | 644.90M |
| Gross profit | 84.00M | 79.50M | 82.20M | 77.30M | 84.40M | 103.70M |
| Selling & admin expenses | 63.50M | 62.40M | 63.80M | 57.60M | 64.50M | 65.40M |
| Research & development | 7.60M | 7.80M | 7.80M | 8.80M | 8.50M | 8.80M |
| Operating profit | 12.90M | 9.30M | 10.60M | 10.90M | 11.40M | 29.50M |
| Pretax profit | 4.90M | -153.30M | 600.00K | 2.00M | 4.20M | 30.00M |
| Tax | 7.40M | 7.20M | 8.70M | 2.60M | 19.20M | 18.10M |
| Net profit | -2.50M | -160.50M | -8.10M | -600.00K | -15.00M | 11.90M |
| Basic EPS | 0 | -4 | 0 | 0 | 0 | 0 |
| Diluted EPS | -0.11 | -3.58 | -0.24 | -0.07 | -0.40 | 0.19 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 462.90M | 467.00M | 545.10M | 1.14B | 1.10B | 893.20M | 970.10M | 959.70M |
| Cash & ST investments | 144.10M | 162.50M | 200.30M | 466.50M | 358.80M | 307.00M | 313.90M | 311.80M |
| Inventory | 186.10M | 172.40M | 180.40M | 379.20M | 443.90M | 374.50M | 381.00M | 390.90M |
| Total assets | 965.50M | 1.02B | 1.10B | 2.03B | 1.96B | 1.87B | 1.92B | 1.73B |
| Total current liabilities | 139.30M | 210.60M | 201.20M | 469.10M | 389.20M | 310.00M | 335.60M | 300.70M |
| Short-term debt | 9.70M | 22.00M | 19.10M | 39.40M | 37.90M | 35.70M | 34.60M | 30.10M |
| Long-term debt | 331.60M | 283.40M | 261.60M | 529.90M | 493.00M | 461.20M | 476.50M | 467.00M |
| Total liabilities | 514,500,000.00 | 566,800,000.00 | 551,300,000.00 | 1,132,700,000.00 | 1,023,900,000.00 | 970,500,000.00 | 984,100,000.00 | 944,900,000.00 |
| Total equity | 451.00M | 452.50M | 551.20M | 892.70M | 937.00M | 897.20M | 935.80M | 784.10M |
| Retained earnings | 149.70M | 140.30M | 217.90M | 337.40M | 377.80M | 346.70M | 370.40M | 189.20M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 947.80M | 955.80M | 941.40M | 959.70M | 1.10B | 1.16B |
| Cash & ST investments | 317.60M | 327.40M | 314.10M | 311.80M | 323.50M | 255.90M |
| Inventory | 374.60M | 375.60M | 382.20M | 390.90M | 481.90M | 629.90M |
| Total assets | 1.89B | 1.75B | 1.72B | 1.73B | 1.86B | 1.92B |
| Total current liabilities | 313.20M | 312.00M | 293.40M | 300.70M | 357.50M | 424.70M |
| Short-term debt | 28.60M | 28.60M | 28.50M | 30.10M | 20.50M | 21.50M |
| Long-term debt | 470.90M | 468.40M | 466.50M | 467.00M | 601.90M | 599.40M |
| Total liabilities | 954,200,000.00 | 955,800,000.00 | 939,200,000.00 | 944,900,000.00 | 1,153,100,000.00 | 1,201,000,000.00 |
| Total equity | 936.80M | 789.80M | 781.30M | 784.10M | 702.10M | 717.10M |
| Retained earnings | 365.40M | 203.40M | 192.50M | 189.20M | 171.30M | 180.00M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 41.70M | 121.00M | 97.30M | 211.60M | 47.20M | 135.90M | 65.00M | 65.60M |
| Depreciation & amortization | 21.10M | 41.60M | 44.80M | 67.50M | 68.40M | 61.70M | 76.10M | 76.00M |
| Free cash flow | 15.60M | 94.70M | 60.90M | 152.30M | -52.90M | 60.10M | 1.50M | 15.30M |
| Dividends paid | 0 | -600.00K | -- | -- | -300.00K | -200.00K | -500.00K | -100.00K |
| Stock buybacks / issuance | 94.60M | 300.00K | 600.00K | 193.60M | -11.40M | -28.60M | 2.00M | -1.20M |
| Ending cash balance | 144.10M | 162.50M | 200.30M | 466.50M | 358.80M | 307.00M | 313.90M | 311.80M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 28.20M | 29.20M | 100.00K | 8.10M | -33.30M | -41.10M |
| Depreciation & amortization | 19.00M | 18.70M | 19.00M | 19.30M | 19.20M | 19.30M |
| Free cash flow | 15.80M | 12.40M | -10.90M | -2.00M | -42.90M | -57.30M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 0 | -2.30M | 0 | 1.10M | -40.00M | 1.10M |
| Ending cash balance | 317.60M | 327.40M | 314.10M | 311.80M | 323.50M | 255.90M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 9.94 | -2.15 | 16.01 | 17.30 | 4.65 | -3.60 | 2.77 | -22.87 |
| ROA %i | 4.79 | -0.95 | 7.31 | 7.64 | 2.03 | -1.62 | 1.25 | -9.93 |
| ROIC %i | 6.48 | 1.16 | 11.21 | 11.94 | 4.35 | 0.14 | 3.63 | -10.74 |
| 5-year avg ROE %i | 8.93 | 7.24 | 11.54 | 14.04 | 9.15 | 6.44 | 7.43 | -0.35 |
| EBIT margin %i | 5.54 | 2.62 | 8.34 | 8.49 | 5.15 | 2.16 | 5.42 | -5.23 |
| FCF / sales %i | 1.42 | 8.88 | 4.35 | 7.25 | -- | 3.47 | 0.07 | 0.74 |
| Current ratioi | 3.32 | 2.22 | 2.71 | 2.42 | 2.82 | 2.88 | 2.89 | 3.19 |
| Quick ratioi | 1.80 | 1.31 | 1.72 | 1.53 | 1.57 | 1.57 | 1.65 | 1.73 |
| Debt / assetsi | 35.35 | 32.79 | 28.28 | 31.36 | 31.17 | 34.26 | 34.39 | 37.81 |
| LT debt / equityi | 76.00 | 71.49 | 54.96 | 70.18 | 64.57 | 72.02 | 71.62 | 87.71 |
| Interest coveragei | -- | 1.09 | 6.90 | 7.38 | 3.60 | 0.77 | 2.45 | -2.80 |
| Revenue CAGR (3Y) %i | 32.71 | 23.74 | 14.80 | 24.22 | 30.59 | 7.44 | -0.06 | -4.72 |
| Net income CAGR (3Y) %i | -- | -- | 1.10 | 48.35 | -- | -- | -41.68 | -- |
| FCF CAGR (3Y) %i | -- | 109.50 | 22.91 | 113.73 | -- | -0.44 | -78.56 | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 3.30 | -19.47 | -20.61 | -22.87 | -25.88 | -3.44 |
| ROA %i | 1.49 | -8.33 | -8.81 | -9.93 | -10.36 | -1.28 |
| ROIC %i | 3.85 | -8.61 | -9.31 | -10.74 | -11.97 | -0.72 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 5.31 | -3.32 | -3.91 | -5.23 | -5.35 | 2.89 |
| FCF / sales %i | 1.19 | 1.29 | 0.81 | 0.74 | -- | -- |
| Current ratioi | 3.03 | 3.06 | 3.21 | 3.19 | 3.07 | 2.73 |
| Quick ratioi | 1.71 | 1.71 | 1.75 | 1.73 | 1.56 | 1.09 |
| Debt / assetsi | 34.18 | 37.14 | 37.79 | 37.81 | 42.07 | 40.45 |
| LT debt / equityi | 70.85 | 86.16 | 87.56 | 87.71 | 121.02 | 117.91 |
| Interest coveragei | 2.57 | -1.67 | -2.03 | -2.80 | -3.10 | 2.38 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Products is the largest reported line at 88.80% of revenue, across 2 reported segments.
- The next-largest line, Services, is a distant second at 11.20% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Products88.80%
Services11.20%
Quote time 2026-10-08 07:00:15 · For reference only, not investment advice and not tailored to your situation.